Roni Shye - September 20, 2018
In response to the current EpiPen shortage, Walgreens has announced that their pharmacies will be stocking an alternative epinephrine auto-injector, Auvi-Q, in case EpiPen supplies run out. Filling an EpiPen prescription with Auvi-Q will come at no cost for commercially insured patients.
Tori Marsh - August 16, 2018
In the two years since a national controversy erupted over the price of EpiPen injectors, the market for epinephrine auto-injectors has changed dramatically, according to a GoodRx analysis of US prescription fill data.
Where two years ago, EpiPen, manufactured by Mylan pharmaceuticals, had nearly 90% of the market for the medication, today the EpiPen brand auto-injector accounts for just around 10% of fills. See More
Tori Marsh - January 05, 2018
For a large portion of Americans, a simple bee sting or a peanut can cause a fatal allergic reaction called anaphylaxis. Fortunately, in most cases, these symptoms can be treated by a shot to the leg with an epinephrine auto-injector. Unfortunately, one of the most popular autoinjectors EpiPen costs around $630 and it’s generic version epinephrine costs around $320 for a pack of two autoinjectors, making them unaffordable for many people in need. See More
Roni Shye - October 03, 2017
If your child needs to use medication during the school year, making the proper accommodation with required school personnel is an important task for parents to complete at the beginning of the school year.
Here are some tips to help ensure that your child stays healthy during this school year.
Be up to date on the school’s policies and procedures
Every school will have different policies and procedures for students taking medication during school hours. See More
Elizabeth Davis - August 28, 2017
Remember way back in 2016 when we were outraged by the rising cost of EpiPen? How kids and schools couldn’t afford a simple, life-saving treatment? How the company’s CEO was grilled by the government and reporters and they pledged to do something about it?
Well, so much for public outrage. The cost of EpiPen has gone up yet again—by as much as 25%. No, we’re not kidding.
The EpiPen outrage of 2016
It’s been almost exactly year since news broke that EpiPen prices had increased by over 400% since 2007. See More
Elizabeth Davis - August 22, 2017
If you’ve got health insurance, now’s a good time to be paying attention. Each year, prescription coverage – the “formulary” – changes, and yours will likely be changing in 2018.
Express Scripts and Caremark, companies that handle pharmacy benefits for more than 200 million Americans, are removing more than 80 prescription medications from their formularies at the end of 2017. See More
Roni Shye - June 22, 2017
Watch out EpiPen there’s (another) new kid on the block. On June 15, 2017, Adamis Pharmaceuticals received FDA approval for Symjepi, their new epinephrine injection. Symjepi joins Adrenaclick, Auvi-Q, and others as an alternative to the expensive treatment for severe allergic reactions. Adamis also anticipates a low cost for the life-saving medication.
Tori Marsh - January 20, 2017
You might be tired of hearing about the EpiPen pricing controversy after the past couple of months. In 2016, it felt like the the life-saving epinephrine auto-injector would never be affordable, as even generic epinephrine was priced around $300.
Tori Marsh - December 22, 2016
After months of waiting, we finally have some good news for EpiPen users! On December 16th, Mylan announced that epinephrine, the generic for the expensive EpiPen auto-injector, will be available in pharmacies this week.
As you may have heard, over the past couple of months, Mylan Pharmaceuticals, the manufacturer of EpiPen, has been criticized for increasing the price of the epinephrine auto-injector by 400% since 2007, to about $600. See More
Tori Marsh - October 26, 2016
Amidst the recent drama surrounding EpiPen prices, we finally have some good news for epinephrine auto-injectors. The expensive Epipen, and EpiPen Jr, will soon have more competition!
In 2017, manufacturer Kaleo will be re-releasing Auvi-Q, their brand of the epinephrine auto-injector. Auvi-Q was pulled from the market last year, but Kaleo has bought back the rights, and plans to release the alternative auto-injector within the next year. See More